Search

Celine Y Hu

from Belvedere Tiburon, CA
Age ~78
Get Report
Also known as:
Celine Yuan Hu, Celine Te Hu, Celine Y Chu, Celine Y Hw
Phone and address:
75 Mount Tiburon Rd, Tiburon, CA 94920
(415) 342-8315
Related to:
Tam Anh Chu, 67Lena D Chu, 42Bryan D Chu, 44Frank T HuDavid Y Hu, 71Minna L Hu, 42George H Chu, 78Peter Y HuPing Hu Tan-Keith, 54Chun Hu TiErica Hu, 70Taehee S Jung, 55Scott M Bartell, 51Russell K Chung, 48Amy Hu, 70
Connected to:
Abby Hu, 45Allen K Hu, 59Alyssa Hu, 29Anna T Hu, 79Ava Hu, 43Beata Hu, 82Benfang Hu, 45Betty M Hu, 77Billy G Hu, 45Bo Hu, 54

Celine Hu Phones & Addresses

  • 75 Mount Tiburon Rd, Bel Tiburon, CA 94920 (415) 342-8315
  • Belvedere Tiburon, CA
  • Berkeley, CA
  • San Francisco, CA
  • Truckee, CA
  • Oakland, CA
  • El Cerrito, CA
  • 75 Mount Tiburon Rd, Tiburon, CA 94920

Business Records

Name / Title
Company / Classification
Phones & Addresses
Celine Hu
Owner
Ominisense Biotechnology
Diagnostics Device
75 Mt Tiburon Rd, Tiburon, CA 94920

Publications

Us Patents

Hcv Non-Structural Protein Mutants And Uses Thereof

View page
US Patent:
7491808, Feb 17, 2009
Filed:
Aug 26, 2005
Appl. No.:
11/213326
Inventors:
David Chien - Emeryville CA, US
Doris Coit - Emeryville CA, US
Celine Hu - Emeryville CA, US
Sansan Lin - Emeryville CA, US
Assignee:
Novartis Vaccines and Diagnostics, Inc. - Emeryville CA
International Classification:
C07H 21/04
US Classification:
536 234, 435 5, 530350
Abstract:
Modified HCV non-structural proteins are described. The proteins include modified NS3 domains such that proteolytic activity of the NS3 molecule is inhibited. The modified proteins retain conformational epitopes. HCV immunoassays including the modified NS3 molecules are also described.

Microfluidic Detection Of Analytes

View page
US Patent:
8263022, Sep 11, 2012
Filed:
Oct 4, 2006
Appl. No.:
12/088636
Inventors:
Celine Hu - Tiburon CA, US
Assignee:
Headway Technologies, Inc. - Milpitas CA
International Classification:
G01N 27/447
G01N 27/453
US Classification:
422502, 204603, 204453
Abstract:
An apparatus and methods for concentrating samples for application to microfluidic devices are disclosed. The methods involve electrophoresing charged molecules from a high volume sample into a smaller volume. The analyte of interest can be a charged molecule or can be modified to be charged using, for example, one or more ionic moieties.

Molecular Microarrays And Methods For Production And Use Thereof

View page
US Patent:
20040171053, Sep 2, 2004
Filed:
Mar 5, 2004
Appl. No.:
10/794305
Inventors:
Celine Hu - Tiburon CA, US
International Classification:
C12Q001/68
G01N033/53
C12M001/34
US Classification:
435/006000, 435/007100, 435/287200
Abstract:
The present invention provides microarrays comprising microparticles with known addresses, wherein the microparticles are coupled to chemical, biological, and/or cellular entities of interest. The invention also provided methods for producing microarrays.

Prion-Specific Peptide Reagents

View page
US Patent:
20050118645, Jun 2, 2005
Filed:
Aug 13, 2004
Appl. No.:
10/917646
Inventors:
Melissa Michelitsch - Oakland CA, US
Celine Hu - Tiburon CA, US
International Classification:
G01N033/53
C07K014/47
C07K016/18
US Classification:
435007100, 530350000, 530388250
Abstract:
Peptide reagents that interact preferentially with the PrPform of the prion protein are described. Methods of using the reagents or antibodies to the reagents for detection, diagnosis, purification, therapy and prophylaxis for prions and prion-associated diseases are also described.

Prion-Specific Peptide Reagents

View page
US Patent:
20060035242, Feb 16, 2006
Filed:
Feb 11, 2005
Appl. No.:
11/056950
Inventors:
Melissa Michelitsch - Oakland CA, US
Celine Hu - Tiburon CA, US
Michael Connolly - Dublin CA, US
Ronald Zuckermann - El Cerrito CA, US
International Classification:
C12Q 1/68
C12P 21/06
US Classification:
435006000, 435069100
Abstract:
Peptide reagents that interact preferentially with the PrPform of the prion protein are described. Methods of using the reagents or antibodies to the reagents for detection, diagnosis, purification, therapy and prophylaxis for prions and prion-associated diseases are also described.

Prion-Specific Peptide Reagents

View page
US Patent:
20090061462, Mar 5, 2009
Filed:
Mar 27, 2008
Appl. No.:
12/079573
Inventors:
Melissa D. Michelitsch - Oakland CA, US
Celine Yuan-Hwei Hu - Tiburon CA, US
Michael D. Connolly - Dublin CA, US
Ronald Zuckermann - El Cerrito CA, US
International Classification:
G01N 33/567
G01N 33/68
G01N 33/536
US Classification:
435 721, 436 86, 436536
Abstract:
Peptide reagents that interact preferentially with the PrPform of the prion protein are described. Methods of using the reagents or antibodies to the reagents for detection, diagnosis, purification, therapy and prophylaxis for prions and prion-associated diseases are also described.

Isolation Of Pathogenic Prions

View page
US Patent:
20090099343, Apr 16, 2009
Filed:
Jan 13, 2006
Appl. No.:
11/795165
Inventors:
David Peretz - El Cerrito CA, US
Melissa Michelitsch - Berkeley CA, US
Celine Hu - Tiburon CA, US
David Chien - Alamo CA, US
John Hall - Emeryville CA, US
Xuemei Wang - Castro Valley CA, US
Man Gao - San Ramon CA, US
International Classification:
C07K 1/14
US Classification:
530412, 530418
Abstract:
Peptide reagents that interact preferentially with the PrPform of the prion protein are described. Methods of using the reagents for isolation and purification of the PrPisoform are described.

Elisa Assays Using Prion-Specific Peptide Reagents

View page
US Patent:
20090130774, May 21, 2009
Filed:
Jan 13, 2006
Appl. No.:
11/795163
Inventors:
David Peretz - El Cerrito CA, US
Melissa Michelitsch - Berkeley CA, US
Celine Hu - Tiburon CA, US
Xuemei Wang - Castro Valley CA, US
Man Gao - San Ramon CA, US
Michael Connolly - Hercules CA, US
Thomas Horn - Berkeley CA, US
Ronald Zuckermann - El Cerrito CA, US
David Chien - Alamo CA, US
International Classification:
G01N 33/566
US Classification:
436501
Abstract:
Peptide reagents that interact preferentially with the PrPsc form of the prion protein are described for use in detecting PrPsc in biological samples. In particular, ELISA assays are described.
Control profile
Celine Y Hu from Belvedere Tiburon, CA, age ~78 Get Report